Filtered By:
Source: ESC Heart Failure
Procedure: Heart Transplant
This page shows you your search results in order of date.
Order by Relevance | Date
Total 22 results found since Jan 2013.
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
ConclusionsThe use of milrinone compared with dobutamine in patients with ADHF-CS is associated with lower 30 day mortality and improved haemodynamics. These findings warrant further study in future randomized controlled trials.
Source: ESC Heart Failure - June 16, 2023 Category: Cardiology Authors: Eduard Rodenas ‐Alesina,
Fernando Luis Scolari,
Vicki N. Wang,
Darshan H. Brahmbhatt,
Vesna Mihajlovic,
Nicole L. Fung,
Madison Otsuki,
Filio Billia,
Christopher B. Overgaard,
Adriana Luk Tags: Original Article Source Type: research
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
ConclusionsElevated plasma levels of ADM may be a marker of pressure/volume overload in HF patients with PH, as well as long-term prognosis after HT. In line with previous studies, our findings additionally confirm that ADM may be a marker of venous congestion in HF. Further studies are encouraged to establish a deeper understanding of the properties of ADM and its relationship with HF and PH, in order to potentially facilitate clinical management of HF and associated PH.
Source: ESC Heart Failure - May 29, 2023 Category: Cardiology Authors: Abdulla Ahmed,
Kriss Kania,
Hebba Abdul Rahim,
Salaheldin Ahmed,
G öran Rådegran Tags: Original Article Source Type: research
Identifying patients at risk: multi ‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
ConclusionsHM3 patients have a significantly better survival and a lower incidence of ischaemic strokes and pump thrombosis than HVAD patients. This survival difference persisted after 2 years of implantation. Additional research using post-operative variables is warranted to identify which HVAD patients need an upgrade to HM3 or expedited transplantation.
Source: ESC Heart Failure - February 17, 2023 Category: Cardiology Authors: Lieke Numan,
Daniel Zimpfer,
Osnat Itzhaki Ben Zadok,
Emmeke Aarts,
Michiel Morshuis,
Sabina P.W. Guenther,
Julia Riebandt,
Dominik Wiedemann,
Faiz Z. Ramjankhan,
Anne ‐Marie Oppelaar,
Tuvia Ben‐Gal,
Binyamin Ben‐Avraham,
Folkert W. Asse Tags: Original Article Source Type: research
Characteristics and long ‐term survival of patients with left ventricular non‐compaction cardiomyopathy
ConclusionsOur study questions the criteria being used for the diagnosis of LVNC. Further evaluation of CMR variables and association of these findings with demographic variables and survival is mandatory.
Source: ESC Heart Failure - September 16, 2022 Category: Cardiology Authors: Emre Demir,
Selen Bayraktaro ğlu,
Akın Çinkooğlu,
Aytaç Candemir,
Yeşim B. Candemir,
Rıza O. Öztürk,
Ömer F. Dadaş,
Mehmet N. Orman,
Mehdi Zoghi,
Azem Akıllı,
Naim Ceylan,
Cemil Gürgün,
Sanem Nalbantgil Tags: Original Article Source Type: research
Elevated plasma WIF ‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
ConclusionsThe present study demonstrated that LHF-PH patients have higher plasma WIF-1 levels than healthy controls, suggesting that plasma WIF-1 may be a potential future prognostic biomarker in LHF-PH. Its prognostic capability could be further refined by including it in a multi-marker panel. Further studies are needed to establish the potential role of WIF-1 in LHF-PH pathophysiology in larger cohorts to determine its clinical applicability.
Source: ESC Heart Failure - September 9, 2022 Category: Cardiology Authors: Kriss Kania,
Abdulla Ahmed,
Salaheldin Ahmed,
G öran Rådegran Tags: Original Article Source Type: research
Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices
ConclusionsOral milrinone appears safe for long-term use in the outpatient setting when combined with therapeutic monitoring in this complex medical cohort with limited management options. Further study is needed to ascertain whether this treatment is effective in reducing heart failure symptoms and admissions.
Source: ESC Heart Failure - July 30, 2022 Category: Cardiology Authors: Waqas Akhtar,
Charles Butcher,
Andrew Morley ‐Smith,
Fernando Riesgo Gil,
Owais Dar,
Veronica Baston,
John Dunning,
Haifa Lyster Tags: Short Communication Source Type: research
Comparing short ‐term/long‐term outcomes of heart transplants that occur inside and outside of normal working hours
ConclusionThere was no significant difference in clinical outcomes between heart transplants taking place inside or outside of working hours. A high quality of care can be provided for heart transplant patients even during after hours.
Source: ESC Heart Failure - April 23, 2022 Category: Cardiology Authors: Hidefumi Nishida,
Christopher Salerno,
David Onsager,
Tae Song,
Ann Nguyen,
Jonathan Grinstein,
Bow Chung,
Bryan Smith,
Sara Kalantari,
Nitasha Sarswat,
Gene Kim,
Sean Pinney,
Valluvan Jeevanandam,
Takeyoshi Ota Tags: Original Article Source Type: research
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience
ConclusionsHeart transplantation is a curative treatment for ARVC, but due to frequent ventricular arrhythmias and RV predominant pathology, patients require unique considerations in regard to timing of evaluation, haemodynamic support options, and wait listing qualification.
Source: ESC Heart Failure - December 25, 2021 Category: Cardiology Authors: Paul J. Scheel,
Katherine Giuliano,
Crystal Tichnell,
Cynthia James,
Brittney Murray,
Harikrishna Tandri,
Debra Carter,
Tracey Fehr,
Priya Umapathi,
Joban Vaishnav,
Sabra C. Lewsey,
Steven Hsu,
Hugh Calkins,
Kavita Sharma,
Chun Woo Choi,
Ni Tags: Original Article Source Type: research
Peripheral microvascular dysfunction is associated with plaque progression and adverse long ‐term outcomes in heart transplant patients
ConclusionsPeripheral endothelial dysfunction is associated with increased plaque progression and adverse long-term cardiovascular outcomes in transplant patients. PED assessment might be a useful clinical tool for risk stratification after heart transplantation.
Source: ESC Heart Failure - September 12, 2021 Category: Cardiology Authors: Ilke Ozcan,
Takumi Toya,
Michel T. Corban,
Ali Ahmad,
Lilach O. Lerman,
Sudhir S. Kushwaha,
Amir Lerman Tags: Original Research Article Source Type: research
Atrial fibrillation before heart transplantation is a risk factor for post ‐transplant atrial fibrillation and mortality
ConclusionsAtrial fibrillation before HTX is a risk factor for post-transplant AF, permanent pacemaker implantation, and mortality after HTX.
Source: ESC Heart Failure - August 28, 2021 Category: Cardiology Authors: Fabrice F. Darche,
Matthias Helmschrott,
Ann ‐Kathrin Rahm,
Dierk Thomas,
Patrick A. Schweizer,
Tom Bruckner,
Philipp Ehlermann,
Michael M. Kreusser,
Gregor Warnecke,
Norbert Frey,
Rasmus Rivinius Tags: Original Research Article Source Type: research
Trends, risk factors, and outcomes of post ‐operative stroke after heart transplantation: an analysis of the UNOS database
ConclusionsPost-operative stroke after HTx is infrequent but associated with higher mortality. Redo sternotomy, LVAD, and ECMO support at HTx are among the risk factors identified.
Source: ESC Heart Failure - August 25, 2021 Category: Cardiology Authors: Paulino Alvarez,
Takeshi Kitai,
Toshihiro Okamoto,
Hiromichi Niikawa,
Kenneth R. McCurry,
Adamantia Papamichail,
Ilias Doulamis,
Alexandros Briasoulis Tags: Original Research Article Source Type: research
Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation
ConclusionsLeft ventricular assist device therapy can impair the outcome after HTx. However, the occurrence of LVAD complications may not impact on outcome after HTx. Thus, we cannot support the prioritization or discrimination of HTx candidates according to distinct mechanical circulatory support ‐associated complications. Future allocation strategies have to respect that device‐related complications may define urgency but do not impact on the outcome after HTx.
Source: ESC Heart Failure - March 29, 2021 Category: Cardiology Authors: Moritz Benjamin Immohr,
Udo Boeken,
Franziska Mueller,
Emir Prashovikj,
Michiel Morshuis,
Charlotte B öttger,
Hug Aubin,
Jan Gummert,
Payam Akhyari,
Artur Lichtenberg,
René Schramm Tags: Original Research Article Source Type: research
Propensity score ‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
ConclusionsSurvival was not significantly different between both groups after PS matching, but was better for HM3, with a significantly lower incidence of haemorrhagic stroke and pump thrombosis for HM3. These results need to be interpreted carefully, because matching may have introduced greater imbalance on unmeasured covariates. A multicentre approach of carefully selected centres is recommended to enlarge the number of matched patients.
Source: ESC Heart Failure - February 26, 2021 Category: Cardiology Authors: Lieke Numan,
Faiz Z. Ramjankhan,
Daniel L. Oberski,
Martinus I.F.J. Oerlemans,
Emmeke Aarts,
Monica Gianoli,
Joris J. Van Der Heijden,
Nicolaas De Jonge,
Niels P. Van Der Kaaij,
Christiaan L. Meuwese,
Mostafa M. Mokhles,
Anne ‐Marie Oppelaar, Tags: Original Research Article Source Type: research
Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
ConclusionsLevosimendan may be a safe and effective alternative for pulmonary hypertension reversibility assessment or a valuable pre ‐test medical optimization tool in end‐stage heart failure patient assessment for heart transplantation offering extended haemodynamic benefits. Whether it increases the rate of positive responses or allows a better selection of candidates to heart transplantation remains to be established.
Source: ESC Heart Failure - February 23, 2021 Category: Cardiology Authors: Marta Tavares ‐Silva,
Francisca Saraiva,
Roberto Pinto,
Sandra Amorim,
João Carlos Silva,
Adelino F. Leite‐Moreira,
Maria Júlia Maciel,
André P. Lourenço Tags: Original Research Article Source Type: research
